GlassScriptPhysician profile
Tejiri Ojaruega
NPI 1518654086
$482.00
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $303 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $97.48 | 2023-2024 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.50 | 2023-2024 | Relistor |
| Coloplast Corp | $67.88 | 2024 | |
| Forte Bio-Pharma LLC | $47.12 | 2023-2024 | Prolate, Nalocet |
| Abbvie INC. | $43.54 | 2023-2024 | |
| Scilex Pharmaceuticals INC. | $33.79 | 2023-2024 | Ztlido |
| Fidia Pharma USA INC. | $23.85 | 2023 | Hymovis, Triluron |
| Valinor Pharma, LLC | $21.91 | 2023 | Movantik |
| Medtronic, INC. | $21.83 | 2023 | Kyphon Express II Kyphopak Tray |
| Siemens Medical Solutions USA, INC. | $21.31 | 2023 | Cios Select |
| Bioventus LLC | $20.86 | 2023 | Durolane |
| Kowa Pharmaceuticals America, INC. | $12.93 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejiri Ojaruega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.